Insight
Robert Orlowski
Photo of Robert Z. Orlowski from faculty.mdanderson.org

Myeloma Paper of the Day, May 11th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:

“Myeloma Paper of the Day: MYC inhibition potentiates CD8+ cytotoxic T-cell activity against myeloma and overcomes immunomodulatory drug resistance in pre-clinical models.”

Source: Robert Orlowski/X

MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance

Authors: Lorraine Davis, Zachary Walker, Lauren Reiman, Sarah Parzych, Brett Stevens, Craig Jordan, Peter Forsberg, and Daniel Sherbenou.

Myeloma Paper of the Day

Other insights by Robert Orlowski on OncoDaily.

Brett Stevens cancer Craig Jordan Daniel Sherbenou Lauren Reiman Lorraine Davis MD Anderson Cancer Center multiple myeloma MYC inhibition OncoDaily Oncology Peter Forsberg Robert Orlowski Sarah Parzych Zachary Walker